Article Versions Notes

Mulgaonkar N, Wang H, Zhang J, Roundy CM, Tang W, Chaki SP, Pauvolid-Corrêa A, Hamer GL, Fernando S. Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant. Pharmaceutics. 2023; 15(7):1891. https://doi.org/10.3390/pharmaceutics15071891

Mulgaonkar, Nirmitee, Haoqi Wang, Junrui Zhang, Christopher M. Roundy, Wendy Tang, Sankar Prasad Chaki, Alex Pauvolid-Corrêa, Gabriel L. Hamer, and Sandun Fernando. 2023. "Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant" Pharmaceutics 15, no. 7: 1891. https://doi.org/10.3390/pharmaceutics15071891

Mulgaonkar, N., Wang, H., Zhang, J., Roundy, C. M., Tang, W., Chaki, S. P., Pauvolid-Corrêa, A., Hamer, G. L., & Fernando, S. (2023). Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant. Pharmaceutics, 15(7), 1891. https://doi.org/10.3390/pharmaceutics15071891